News

Spineart has announced the 510k approval for their TRYPTIK® CA cervical interbody cage. The cage follows Spineart’s unique load sharing concept, which is designed to accelerate and improve the fusion process. To date the TRYPTIK®CA cervical cage has been implanted over 5.000 times worldwide.

Spineart has announced the 510k approval for theirJULIET® lumbar interbody fusion cage range. The range includes ALIF, PLIF and TLIF cages that all follow Spineart’s unique load sharing concept, which is designed to accelerate and improve the fusion process. To date the JULIET® cages have been implanted over 9.000 times worldwide.

Spineart has announced the 510k approval for their ROMEO® posterior fixation system. The screws are designed to center themselves while being inserted into the pedicle to facilitate and increase the safety of the surgical procedure. To date the ROMEO® screws have been implanted over 20.000 times worldwide.

Spineart, leader of a new spinal generation, is proud to announce the opening of its US subsidiary the 1st of September 2009. The office is located in Manhattan, New York City. This furthermore underlines the ambitious execution of Spineart’s corporate strategy and its 2nd geographic development phase after the establishment in Europe. The new US headquarter includes the sales, scientific and R&D departments in order to meet the US market demands.

Geneva, October 28th 2008. Spineart, leader of a new spinal generation, announces the appointment of Mr. Jean-Claude Donnarel as its Director of French Sales. Jean-Claude joins with a 14 year experience in managing leading French sales teams, having served as Director of Stryker Howmedica’s trauma unit, and then as General Manager of Medtronic spine. Stéphane Mugnier, Spineart co-CEO and head of Marketing & Sales said: ” We are proud to welcome Jean-Claude as the head of our French Sales force. Thanks to his vast experience in the spine business in France, and having managed the leading sales team there, we believe that we will be able to continue our striking expansion. Spineart has already reached 9% of the French spinal market share and clearly has the capacity and ambition to do much better with the reinforcement of its sales force as well as the continuous roll-out of its innovative but simple spinal implants.”

Geneva, October 16th 2008. Spineart, leader of a new spinal generation, announces the completion of its innovative range of lumbar fusion implants with the launch of its minimally invasive TLIF cage. The JULIET®TL benefits from the range’s typical slit, designed to stimulate the fusion by exposing the graft to tension (according to Wolff’s law). The JULIET®TL can be implanted through a minimally invasive transforaminal approach in order to achieve maximum efficiency and minimal disruption. Dr. Frischhmuth from the Neurosurgical department at the Elbeklinikum in Stade, Germany, states:” Once again, Spineart has managed to simplify our work, shortening surgery time and reducing the number of tools necessary, whilst giving the surgeons and patients the benefits of a less traumatic approach.”